Cardiol Therapeutics Inc.

CRDL | NASDAQ

Price Alert Chart Builder DCF Calculator

$1.89

+$0.03 (+1.61%)

At close: Sep 22, 2026, 4:00 PM ET

$1.92

+$0.03 (+1.59%)

After-hours: Sep 22, 2026, 7:46 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

+1.61%

(1D)

Rating

Updated: Aug 31, 2026

Fundamentals Weak

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $217.86M

1D Range

1.86 1.95

52W Range

0.88 2.34

Valuation (TTM)

PE -7.14

PB 12.29

EV/EBITDA -7.34

Valuation (NTM)

Forward PE N/A

Forward PEG 0.22

Price Target $8

Cash Flow

FCF Yield -8.1%

SBC Adj. FCF Yield -11.8%

SBC Impact -46.9%

Margins

Gross Margin 0.0%

Operating Margin 0.0%

FCF Margin N/A

Growth (CAGR)

Revenue 3Y | 5Y N/A | -100.0%

Dil EPS 3Y | 5Y 10.3% | 8.9%

FCF 3Y | 5Y -4.4% | 1.3%

Returns

ROA -116.1%

ROE -180.1%

ROIC -148.6%

Financial Health

Net Cash

C$27.74M ($19.94M)

Current Ratio 5.55

Interest Coverage 0.00

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Cardiol Therapeutics Inc. is a clinical-stage life sciences firm dedicated to discovering and advancing anti-fibrotic and anti-inflammatory therapies for cardiovascular disease (CVD). Its leading cand...

Sector Healthcare

Industry Drug Manufacturers - Specialty & Generic

Employees 18

IPO Date Jan 14, 2019

Website www.cardiolrx.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.

Analyst Summary

# of Analysts

Consensus

Buy

Price Target

Upside

+323.28%

Buy (2)

Hold (0)

Sell (0)

Analyst Details ➞